84 related articles for article (PubMed ID: 18457020)
1. Expression of genes for thioredoxin 1 and thioredoxin 2 in multidrug resistance ovarian carcinoma cells SKVLB.
Kalinina EV; Chernov NN; Saprin AN; Kotova YN; Gavrilova YA; Chermnykh NS; Shcherbak NP
Bull Exp Biol Med; 2007 Sep; 144(3):301-3. PubMed ID: 18457020
[TBL] [Abstract][Full Text] [Related]
2. Why does chemotherapy stop affecting the cells of ovarian and breast tumors?
Kalinina EV; Chernov NN
Future Oncol; 2018 May; 14(12):1137-1140. PubMed ID: 29629566
[No Abstract] [Full Text] [Related]
3. Thioredoxin 1 upregulates FOXO1 transcriptional activity in drug resistance in ovarian cancer cells.
Wang J; Yang H; Li W; Xu H; Yang X; Gan L
Biochim Biophys Acta; 2015 Mar; 1852(3):395-405. PubMed ID: 25483711
[TBL] [Abstract][Full Text] [Related]
4. Role of thioredoxins in the response of Saccharomyces cerevisiae to oxidative stress induced by hydroperoxides.
Garrido EO; Grant CM
Mol Microbiol; 2002 Feb; 43(4):993-1003. PubMed ID: 11929546
[TBL] [Abstract][Full Text] [Related]
5. Expression of genes for redox-dependent glutathione S-transferase isoforms GSTP1-1 and GSTA4-4 in tumor cell during the development doxorubicin resistance.
Kalinina EV; Chernov NN; Saprin AN; Kotova YN; Remizov VI; Shcherbak NP
Bull Exp Biol Med; 2007 Mar; 143(3):328-30. PubMed ID: 18225754
[TBL] [Abstract][Full Text] [Related]
6. Role of thioredoxin 1 and thioredoxin 2 on proliferation of human adipose tissue-derived mesenchymal stem cells.
Song JS; Cho HH; Lee BJ; Bae YC; Jung JS
Stem Cells Dev; 2011 Sep; 20(9):1529-37. PubMed ID: 21158569
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells.
Xu J; Wu J; Fu C; Teng F; Liu S; Dai C; Shen R; Jia X
J Cell Physiol; 2018 Jun; 233(6):5034-5043. PubMed ID: 29219179
[TBL] [Abstract][Full Text] [Related]
8. Analysis of MDR genes expression and cross-resistance in eight drug resistant ovarian cancer cell lines.
Januchowski R; Sterzyńska K; Zaorska K; Sosińska P; Klejewski A; Brązert M; Nowicki M; Zabel M
J Ovarian Res; 2016 Oct; 9(1):65. PubMed ID: 27756418
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
[TBL] [Abstract][Full Text] [Related]
10. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
Zhu L; Lang J; Shen K
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
[TBL] [Abstract][Full Text] [Related]
11. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
[TBL] [Abstract][Full Text] [Related]
12. A single glutaredoxin or thioredoxin gene is essential for viability in the yeast Saccharomyces cerevisiae.
Draculic T; Dawes IW; Grant CM
Mol Microbiol; 2000 Jun; 36(5):1167-74. PubMed ID: 10844700
[TBL] [Abstract][Full Text] [Related]
13. Redox proteins thioredoxin 1 and thioredoxin 2 support retinal ganglion cell survival in experimental glaucoma.
Munemasa Y; Ahn JH; Kwong JM; Caprioli J; Piri N
Gene Ther; 2009 Jan; 16(1):17-25. PubMed ID: 18701913
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance by small interfering double-stranded RNAs in ovarian cancer cells.
Zhang T; Guan M; Jin HY; Lu Y
Gynecol Oncol; 2005 May; 97(2):501-7. PubMed ID: 15863151
[TBL] [Abstract][Full Text] [Related]
15. Expanding the roles for pregnane X receptor in cancer: proliferation and drug resistance in ovarian cancer.
Gupta D; Venkatesh M; Wang H; Kim S; Sinz M; Goldberg GL; Whitney K; Longley C; Mani S
Clin Cancer Res; 2008 Sep; 14(17):5332-40. PubMed ID: 18765524
[TBL] [Abstract][Full Text] [Related]
16. Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells.
Buys TP; Chari R; Lee EH; Zhang M; MacAulay C; Lam S; Lam WL; Ling V
Genes Chromosomes Cancer; 2007 Dec; 46(12):1069-79. PubMed ID: 17726699
[TBL] [Abstract][Full Text] [Related]
17. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
18. An M(r) 7-kDa membrane protein overexpressed in human multidrug-resistant ovarian cancer cells.
Yang X; Pagé M
Cancer Lett; 1995 Jan; 88(2):171-8. PubMed ID: 7874690
[TBL] [Abstract][Full Text] [Related]
19. [Reversal of multi-drug resistance in ovarian cancer cell by RNA interference].
Lou JY; Peng ZL; Zheng Y; Wang H; He B; Wang HJ
Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):413-6. PubMed ID: 16831368
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin genes in Saccharomyces cerevisiae: map positions of TRX1 and TRX2.
Muller EG
Yeast; 1992 Feb; 8(2):117-20. PubMed ID: 1561834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
